Sebacia

company

About

Sebacia is a commercial-stage dermatology company that develops an alternative to the topical and systemic drugs for the treatment of acne.

  • 1 - 10

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$16M
Industries
Biotechnology,Medical,Medical Device
Founded date
Jan 1, 2010
Number Of Employee
1 - 10
Operating Status
Active

Sebacia, Inc. is a private medical device company dedicated to creating breakthrough topical therapies for the treatment of dermatological conditions affecting millions of people. Sebacia's goal is to provide a better alternative to the daily use of topical and systemic drugs currently available for the treatment of acne. Sebacia's patented microparticles technology was invented at Rice University, and the proprietary dermatology applications were further developed with researchers from the Wellman Center of Photomedicine at Massachusetts General Hospital. Sebacia is located in Duluth, Georgia.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$48M
Sebacia has raised a total of $48M in funding over 2 rounds. Their latest funding was raised on Jul 25, 2017 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 25, 2017 Debt Financing $16M 1 Hercules Capital Detail
Jul 25, 2017 Series D $20M 1 Versant Ventures Detail
Jun 25, 2015 Series C $12M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Sebacia is funded by 2 investors. Hercules Capital and Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Debt Financing
Versant Ventures Yes Series D